The short answer
High caffeine intake may add to amantadine-related nervousness, insomnia or other stimulant-like symptoms. A universal caffeine-avoidance rule or protective spacing interval has not been established.
What this answer covers
Caffeine from drinks, supplements and combination products; amount and habitual use matter.
- Supplement or preparation
- Caffeine
- Medication ingredient
- amantadine
The label calls for observation with stimulants
Immediate-release amantadine labeling calls for careful observation when it is taken with CNS stimulants. Amantadine can itself cause nervousness or insomnia. This supports reviewing high caffeine intake without proving that every amount causes an interaction.
The human caffeine evidence is indirect
A caffeine-alone study found increased blood pressure in selected young men, with greater response in those with borderline hypertension. It did not test amantadine. No exact-pair event rate or safe caffeine threshold was established.
Avoidance and spacing are different claims
The inspected sources do not require all amantadine users to avoid caffeine, and do not show that taking it a few hours apart prevents symptoms. A stimulant precaution is not a proven drug-absorption interaction.
Review total intake if symptoms appear
Count caffeine from drinks and supplements and discuss changes if sleep, anxiety or palpitations worsen. Do not increase caffeine to counter drowsiness before driving, and do not change amantadine on your own.
Evidence and practical considerations
Timing & monitoring
Label recommends careful observation with stimulants, not mandatory caffeine avoidance or a demonstrated protective spacing interval. No exact human timing study identified.
- Exact scope
- Caffeine from drinks, supplements and combination products; amount and habitual use matter. with Oral amantadine hydrochloride immediate-release capsules; GOCOVRI extended-release considered separately.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- No unmeasured pair incidence, blanket class transfer or arbitrary spacing interval.
Factors that may matter: Preparation; Dose; Other medicines; Organ function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed amantadine
May cause insomnia, agitation or somnolence; careful observation with CNS stimulants and other CNS-active medicines. Renal elimination and seizure-history precautions.
How this applies: Exact amantadine RxCUI 620 IN, with stated salt/formulation/route bridge.
No exact supplement-combination incidence or validated protective spacing; salt, route and release form limits apply.
Source 2: Original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Forty-eight young men, half with borderline hypertension.
Caffeine raised pressure more in the borderline-hypertension group.
How this applies: Interpreted for amantadine only within the stated exact preparation and endpoint limits.
Caffeine-alone pressure study after abstinence in selected young men; not an amantadine combination, ordinary habitual intake study or timing experiment.
Research assessment: · Open full citations ↗
Side effects & toxicity
Conditional stimulant-like symptom concern with high caffeine intake and exact amantadine label caution about CNS stimulants. No pair rate or universal threshold.
- Exact scope
- Caffeine from drinks, supplements and combination products; amount and habitual use matter. with Oral amantadine hydrochloride immediate-release capsules; GOCOVRI extended-release considered separately.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- No unmeasured pair incidence, blanket class transfer or arbitrary spacing interval.
Factors that may matter: Preparation; Dose; Other medicines; Organ function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed amantadine
May cause insomnia, agitation or somnolence; careful observation with CNS stimulants and other CNS-active medicines. Renal elimination and seizure-history precautions.
How this applies: Exact amantadine RxCUI 620 IN, with stated salt/formulation/route bridge.
No exact supplement-combination incidence or validated protective spacing; salt, route and release form limits apply.
Source 2: Original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Forty-eight young men, half with borderline hypertension.
Caffeine raised pressure more in the borderline-hypertension group.
How this applies: Interpreted for amantadine only within the stated exact preparation and endpoint limits.
Caffeine-alone pressure study after abstinence in selected young men; not an amantadine combination, ordinary habitual intake study or timing experiment.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Research summary published | |
| Article prepared | |
| Prepared exact amantadine article with formulation-specific evidence and uncertainty. |
Article revision: 9ce5f0b1ea3fd8fc
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.